0001415889-22-012604.txt : 20221215
0001415889-22-012604.hdr.sgml : 20221215
20221215191237
ACCESSION NUMBER: 0001415889-22-012604
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221213
FILED AS OF DATE: 20221215
DATE AS OF CHANGE: 20221215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Torley Helen
CENTRAL INDEX KEY: 0001528185
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32335
FILM NUMBER: 221466113
MAIL ADDRESS:
STREET 1: C/O ONYX PHARMACEUTICALS, INC.
STREET 2: 249 EAST GRAND AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HALOZYME THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001159036
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 880488686
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11388 SORRENTO VALLEY ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121-1345
BUSINESS PHONE: (858) 794-8889
MAIL ADDRESS:
STREET 1: 11388 SORRENTO VALLEY ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121-1345
FORMER COMPANY:
FORMER CONFORMED NAME: HALOZYME THERAPEUTICS INC
DATE OF NAME CHANGE: 20040312
FORMER COMPANY:
FORMER CONFORMED NAME: GLOBAL YACHT SERVICES INC
DATE OF NAME CHANGE: 20010912
4
1
form4-12162022_121213.xml
X0306
4
2022-12-13
0001159036
HALOZYME THERAPEUTICS, INC.
HALO
0001528185
Torley Helen
C/O HALOZYME THERAPEUTICS, INC.
11388 SORRENTO VALLEY ROAD
SAN DIEGO
CA
92121
true
true
false
false
PRESIDENT AND CEO
Common Stock
2022-12-13
4
M
0
10000
14.66
A
597177
D
Common Stock
2022-12-13
4
S
0
9507
58.639
D
587670
D
Common Stock
2022-12-13
4
S
0
493
59.12
D
587177
D
Common Stock
2022-12-14
4
M
0
10000
14.66
A
597177
D
Common Stock
2022-12-14
4
S
0
10000
58.298
D
587177
D
Common Stock
2022-12-15
4
M
0
10000
14.66
A
597177
D
Common Stock
2022-12-15
4
S
0
9104
57.288
D
588073
D
Common Stock
2022-12-15
4
S
0
896
58.197
D
587177
D
Option to Purchase Common Stock
14.66
2022-12-13
4
M
0
10000
14.66
D
2024-01-06
Common Stock
10000
110000
D
Option to Purchase Common Stock
14.66
2022-12-14
4
M
0
10000
14.66
D
2024-01-06
Common Stock
10000
100000
D
Option to Purchase Common Stock
14.66
2022-12-15
4
M
0
10000
14.66
D
2024-01-06
Common Stock
10000
90000
D
The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1.
Represents a weighted average sales price per share. The shares were sold at prices ranging from $58.11 to $59.01. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Represents a weighted average sales price per share. The shares were sold at prices ranging from $58.11 to $58.49. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Represents a weighted average sales price per share. The shares were sold at prices ranging from $57.00 to $57.98. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Represents a weighted average sales price per share. The shares were sold at prices ranging from $58.02 to $58.22. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was January 6, 2014.
/s/ James R. Oehler, Attorney-in-Fact
2022-12-15